1. Home
  2. KOSS vs GBIO Comparison

KOSS vs GBIO Comparison

Compare KOSS & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Koss Corporation

KOSS

Koss Corporation

HOLD

Current Price

$4.85

Market Cap

43.6M

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.22

Market Cap

35.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KOSS
GBIO
Founded
1953
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Electronics/Appliances
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.6M
35.4M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
KOSS
GBIO
Price
$4.85
$5.22
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$10.67
AVG Volume (30 Days)
25.6K
57.4K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,493,080.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
11.58
N/A
52 Week Low
$4.00
$3.00
52 Week High
$8.59
$14.20

Technical Indicators

Market Signals
Indicator
KOSS
GBIO
Relative Strength Index (RSI) 51.05 47.21
Support Level $4.81 $5.14
Resistance Level $4.99 $5.38
Average True Range (ATR) 0.19 0.25
MACD 0.04 0.02
Stochastic Oscillator 71.43 49.35

Price Performance

Historical Comparison
KOSS
GBIO

About KOSS Koss Corporation

Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: